WALTHAM, Mass.--(BUSINESS WIRE)--Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced its new Reference Module in Biomedical Sciences, which will provide biomedical and life science researchers access to reference content updated as science progresses. It is available now for pre-sale; access for users will begin on ScienceDirect in late 2014.
Reference Modules combine thousands of related reference work articles into one source of trustworthy information that is continuously updated by experts. The first modules available to researchers were Chemistry, Molecular Sciences and Chemical Engineering and Earth Systems and Environmental Sciences, beginning in September 2013.
The Reference Module in Biomedical Sciences will include:
- Content from 17 Elsevier’s authoritative, peer-reviewed reference works
- Articles that are continuously reviewed, updated as needed and then time stamped by the expert editorial board
- Intuitive subject hierarchies, designed by the editorial board, that make it easy to navigate and find essential information
- Linking to relevant journal articles and book chapters on ScienceDirect for additional information
Biomedical and life science researchers benefit by gaining access to the most current foundational content that was previously locked up during the lengthy publishing process, typically for five to seven years. Librarians, who are increasingly under pressure to stretch budgets further and secure content that contributes to meaningful research and learning, see value in the Reference Modules’ continuous reviews and updates led by the expert editorial boards.
“Biomedical science is actually an interwoven web of different disciplinary threads,” said Michael Caplan, PhD, MD, Yale School of Medicine and Editor-in-Chief of the Reference Module in Biomedical Sciences. “If you are a cell biologist you might not know what lives under the genetics rock. If you’re a pathologist, you might not know what lives under the epidemiology rock. The architecture of this [Reference Module] will hopefully allow researchers an opportunity to leap from rock to rock, and know which ones they want to turn over and I think that will be the huge advantage.”
- Hear more from Michael Caplan on the new Reference Module in Biomedical Sciences here
The Reference Module in Biomedical Sciences will help researchers access increasingly interdisciplinary content they require. The interdisciplinary subjects in the new module will include: cancer, cell biology, developmental biology, endocrinology, epidemiology and public health, genetics and genomics, human nutrition, immunobiology, medical biotechnology, medical microbiology, neurobiology, pathobiology of human disease, pharmacology, physiology, toxicology and virology.
“We’ve heard from librarians and researchers alike that they are forced to spend a lot of time searching for up-to-date, trustworthy information,” said Suzanne BeDell, Managing Director of Science and Technology Books, Elsevier. “The Reference Modules bring researchers high-quality content presented in a manner that is more useful. Soon life and biomedical science researchers will have content that is updated at the speed of science, makes valued connections between interdisciplinary subjects and, most importantly, saves them time.”
The new Reference Modules in Biomedical Science will be available on ScienceDirect, Elsevier’s full-text scientific database offering journal articles and book chapters from nearly 2,200 peer-reviewed journals, almost 900 serials and more than 25,000 book titles. Existing Reference Modules in Chemistry, Molecular Sciences and Chemical Engineering, and Earth Systems and Environmental Sciences can be found on ScienceDirect. For more information, visit www.ReferenceModules.com.
About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
